|
GW9508
- 品牌：MedKoo
- 產(chǎn)地：美國(guó)
- 貨號(hào)：510279
- cas：885101-89-3
- 發(fā)布日期： 2022-07-20
- 更新日期： 2024-08-12
產(chǎn)品詳請(qǐng)
| 產(chǎn)地 | 美國(guó) |
| 品牌 | MedKoo |
| 貨號(hào) | 510279 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包裝規(guī)格 | 25.0mg; 50.0mg; 100.0mg; 200.0mg; 500.0mg; 1.0g; 2.0g; 5.0g; |
| CAS編號(hào) | 885101-89-3 |
| 純度 | >98%% |
| 是否進(jìn)口 | 是 |
中文名稱:885101-89-3(GW9508)
中文別名:4-[[(3-苯氧苯基)甲基]氨基]苯乙酸
CAS No:885101-89-3
分子式:C22H21NO3
用途:1、GW9508 is a GPR40 full agonist, used to regulate glucose in rats. Can be applied to the treatment of diabetes type 2. GPR120 selective and potent agonist also used in the treatment of diabetes type 2 due to GPR120鈥檚 ability to mediate GLP-1 secretion, insulin sensitization and anti-obesity effe..
安全說(shuō)明:26-39-60-61
危險(xiǎn)品運(yùn)輸編號(hào)：UN 3077 9 / PGIII
中文別名:4-[[(3-苯氧苯基)甲基]氨基]苯乙酸
CAS No:885101-89-3
分子式:C22H21NO3
用途:1、GW9508 is a GPR40 full agonist, used to regulate glucose in rats. Can be applied to the treatment of diabetes type 2. GPR120 selective and potent agonist also used in the treatment of diabetes type 2 due to GPR120鈥檚 ability to mediate GLP-1 secretion, insulin sensitization and anti-obesity effe..
安全說(shuō)明:26-39-60-61
危險(xiǎn)品運(yùn)輸編號(hào)：UN 3077 9 / PGIII
相關(guān)產(chǎn)品：
